Copyright
©The Author(s) 2022.
World J Gastroenterol. Jun 21, 2022; 28(23): 2609-2624
Published online Jun 21, 2022. doi: 10.3748/wjg.v28.i23.2609
Published online Jun 21, 2022. doi: 10.3748/wjg.v28.i23.2609
ICC | 95%CI | ||
Basal | |||
Test1 and test2, reader1 | ROI ADCmean | 0.850 | 0.742–0.800 |
Test1 and test2, reader2 | ROI ADCmean | 0.890 | 0.850-0.820 |
After treatment | |||
Test1 and test2, reader1 | ROI ADCmean | 0.800 | 0.750-0.819 |
Test1 and test2, reader2 | ROI ADCmean | 0.823 | 0.800-0.850 |
Basal | |||
Test1 and test2, reader1 | ADCmean | 0.850 | 0.756-0.920 |
Test1 and test2, reader2 | ADCmean | 0.777 | 0.745-0.812 |
After treatment | |||
Test1 and test2, reader1 | ADCmean | 0.845 | 0.830-0.850 |
Test1 and test2, reader2 | ADCmean | 0.823 | 0.800-0.833 |
Basal | |||
Test1 and test2, reader1 | 10th percentile | 0.820 | 0.880-0.950 |
Test1 and test2, reader2 | 10th percentile | 0.880 | 0.800-0.920 |
After treatment | |||
Test1 and test2, reader1 | 10th percentile | 0.780 | 0.740-0.853 |
Test1 and test2, reader2 | 10th percentile | 0.853 | 0.723-0.901 |
Basal | |||
Test1 and test2, reader1 | 25th percentile | 0.803 | 0.800-0.922 |
Test1 and test2, reader2 | 25th percentile | 0.863 | 0.801-0.895 |
After treatment | |||
Test1 and test2, reader1 | 25th percentile | 0.788 | 0.750-0.837 |
Test1 and test2, reader2 | 25th percentile | 0.820 | 0.780-0.846 |
Basal | |||
Test1 and test2, reader1 | 50th percentile | 0.850 | 0.840-0.920 |
Test1 and test2, reader2 | 50th percentile | 0.845 | 0.790-0.860 |
After treatment | |||
Test1 and test2, reader1 | 50th percentile | 0.821 | 0.800-0.913 |
Test1 and test2, reader2 | 50th percentile | 0.833 | 0.800-0.897 |
Basal | |||
Test1 and test2, reader1 | 75th percentile | 0.821 | 0.790-0.860 |
Test1 and test2, reader2 | 75th percentile | 0.859 | 0.820-0.920 |
After treatment | |||
Test1 and test2, reader1 | 75th percentile | 0.851 | 0.790-0.880 |
Test1 and test2, reader2 | 75th percentile | 0.837 | 0.791-0.856 |
Basal | |||
Test1 and test2, reader1 | 90th percentile | 0.850 | 0.820-0.890 |
Test1 and test2, reader2 | 90th percentile | 0.880 | 0.850-0.960 |
After treatment | |||
Test1 and test2, reader1 | 90th percentile | 0.831 | 0.800-0.902 |
Test1 and test2, reader2 | 90th percentile | 0.901 | 0.850-0.975 |
Basal | |||
Test1 and test2, reader1 | Skewness | 0.920 | 0.900-0.940 |
Test1 and test2, reader2 | Skewness | 0.901 | 0.880-0.923 |
After treatment | |||
Test1 and test2, reader1 | Skewness | 0.931 | 0.920-0.950 |
Test1 and test2, reader2 | Skewness | 0.889 | 0.877-0.910 |
Basal | |||
Test1 and test2, reader1 | Kurtosis | 0.920 | 0.890-0.950 |
Test1 and test2, reader2 | Kurtosis | 0.910 | 0.850-0.960 |
After treatment | |||
Test1 and test2, reader1 | Kurtosis | 0.890 | 0.850-0.960 |
Test1 and test2, reader2 | Kurtosis | 0.880 | 0.840-0.982 |
- Citation: Jiménez de los Santos ME, Reyes-Pérez JA, Domínguez Osorio V, Villaseñor-Navarro Y, Moreno-Astudillo L, Vela-Sarmiento I, Sollozo-Dupont I. Whole lesion histogram analysis of apparent diffusion coefficient predicts therapy response in locally advanced rectal cancer. World J Gastroenterol 2022; 28(23): 2609-2624
- URL: https://www.wjgnet.com/1007-9327/full/v28/i23/2609.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i23.2609